Market revenue in 2023 | USD 11,492.6 million |
Market revenue in 2030 | USD 16,103.1 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Product Design & Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 47.4% in 2023. Horizon Databook has segmented the North America biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
Moreover, the adoption of biotechnology & pharmaceutical services is accelerating the development of blockbuster drugs for various disease types across the U.S., Canada, Mexico, and Puerto Rico. This has increased the demand for various clinical trials and regulatory services for commercializing drugs.
In addition, outsourcing facilities offer a diverse portfolio of R&D projects at various development stages, making the pharmaceutical & biotechnology companies one step closer to taking the next viable medicine breakthrough to the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into North America biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account